Chimerix im COVID-19 Jahr (Seite 4)
eröffnet am 25.05.20 10:01:37 von
neuester Beitrag 20.02.23 18:01:12 von
neuester Beitrag 20.02.23 18:01:12 von
Beiträge: 37
ID: 1.325.288
ID: 1.325.288
Aufrufe heute: 0
Gesamt: 3.605
Gesamt: 3.605
Aktive User: 0
ISIN: US16934W1062 · WKN: A1T65B · Symbol: CXF
0,8420
EUR
+1,20 %
+0,0100 EUR
Letzter Kurs 13:08:49 Tradegate
Neuigkeiten
24.04.24 · globenewswire |
16.04.24 · globenewswire |
21.03.24 · globenewswire |
29.02.24 · globenewswire |
27.02.24 · globenewswire |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,9000 | +59,66 | |
4,7450 | +35,57 | |
0,5250 | +19,08 | |
5,8900 | +17,80 | |
12,800 | +17,43 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,6900 | -14,50 | |
2,8150 | -15,21 | |
3,0400 | -19,95 | |
1,9500 | -25,14 | |
0,5121 | -30,80 |
Beitrag zu dieser Diskussion schreiben
$CMRX Smallpox news with BARDA coming ? 🤔 👍
COVID-19 Therapeutics: The Leading Contenders
https://seekingalpha.com/article/4351875-covidminus-19-thera…
🤔 👍
https://seekingalpha.com/article/4351875-covidminus-19-thera…
🤔 👍
Why Chimerix Pivoted To Take On COVID-19
Rob Wright, chief editor of Life Science Leader, recently conducted a virtual roundtable with three CEOs of publicly traded biopharmaceutical companies (view full video here). In this clip, Mike Sherman, CEO of Chimerix (NASDAQ: CMRX), discusses the decision making behind an R&D pivot and the initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in acute lung injury for patients with severe COVID-19.
https://www.lifescienceleader.com/doc/why-chimerix-pivoted-t…
🤔
Rob Wright, chief editor of Life Science Leader, recently conducted a virtual roundtable with three CEOs of publicly traded biopharmaceutical companies (view full video here). In this clip, Mike Sherman, CEO of Chimerix (NASDAQ: CMRX), discusses the decision making behind an R&D pivot and the initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in acute lung injury for patients with severe COVID-19.
https://www.lifescienceleader.com/doc/why-chimerix-pivoted-t…
🤔
🙂 👍
Antwort auf Beitrag Nr.: 63.790.073 von Schlood am 25.05.20 10:01:37Aus Stocktwits:
https://clinicaltrials.gov/ct2/show/NCT04389840?term=Chimeri…
👍
https://clinicaltrials.gov/ct2/show/NCT04389840?term=Chimeri…
👍
24.04.24 · globenewswire · Chimerix |
16.04.24 · globenewswire · Chimerix |
21.03.24 · globenewswire · Chimerix |
29.02.24 · globenewswire · Chimerix |
27.02.24 · globenewswire · Chimerix |
22.02.24 · globenewswire · Chimerix |
29.12.23 · globenewswire · Chimerix |
24.11.23 · globenewswire · Chimerix |
16.11.23 · globenewswire · Chimerix |
02.11.23 · globenewswire · Chimerix |